Annual report pursuant to Section 13 and 15(d)

Consolidated Income Statements

v3.22.4
Consolidated Income Statements - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues:    
Total revenues $ 101,911,409 $ 80,859,653
Cost of revenues:    
Total cost of revenues 9,830,162 8,513,777
Selling and marketing expenses 13,962,709 11,424,416
Depreciation and amortization 7,643,980 6,088,947
General and administrative expenses 67,987,482 49,453,305
Total selling, general and administrative expenses 89,594,171 66,966,668
Net loss on disposition or impairment 410,215 26,789
Income from operations 2,076,861 5,352,419
Other expense, net (133,101) (69,878)
Income before income tax expense (benefit) 1,943,760 5,282,541
Income tax expense (benefit) 766,510 (1,293,229)
Net income $ 1,177,250 $ 6,575,770
Earnings per share:    
Basic earnings per share (in dollars per share) $ 0.08 $ 0.46
Diluted earnings per share (in dollars per share) $ 0.08 $ 0.44
Basic weighted average shares (in shares) 14,488,314 14,319,448
Diluted weighted average shares (in shares) 14,868,093 14,935,577
Revenues from company-owned or managed clinics    
Revenues:    
Total revenues $ 59,422,294 $ 44,348,234
Royalty fees    
Revenues:    
Total revenues 26,190,531 22,062,989
Franchise fees    
Revenues:    
Total revenues 2,441,325 2,659,097
Cost of revenues:    
Cost of revenues 8,462,503 7,408,125
Advertising fund revenue    
Revenues:    
Total revenues 7,456,696 6,298,924
Software fees    
Revenues:    
Total revenues 4,290,739 3,383,856
Cost of revenues:    
Cost of revenues 1,367,659 1,105,652
Regional developer fees    
Revenues:    
Total revenues 659,099 848,640
Other revenues    
Revenues:    
Total revenues $ 1,450,725 $ 1,257,913